Form 4 for ESAB ESAB Corp
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001209191-23-012850 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-24 | 2023-02-22 | ESAB | Hix Christopher M | Dir | M - OptEx | — | +1,673 | 37.5K | +5% | — |
| D | 2023-02-24 | 2023-02-23 | ESAB | Hix Christopher M | Dir | S - Sale+OE | $57.62 | -837 | 36.6K | -2% | -$48.2K |
| D | 2023-02-24 | 2023-02-22 | ESAB | Hix Christopher M | Dir | M - OptEx | $0.00 | -1,673 | 1,673 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2023-02-22 | M | A | 1,673 | — | 37,481 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. |
| 2 | Common | Common stock, par value $0.001 | 2023-02-23 | S | D | 837 | $57.62 | 36,644 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2023-02-22 | M | D | 1,673 | $0.00 | 1,673 | D | — · 2023-02-22 to 2024-02-22 | 1,673 Common stock, par value $0.001 | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. (F3) One-third of these restricted stock units vested on February 17, 2023. The remaining restricted stock units will vest in two equal annual installments on February 17, 2024 and February 17, 2025. |